Transarterial infusion chemotherapy with epirubicin in water-in-oil-in-water emulsion for recurrent hepatocellular carcinoma in the residual liver after hepatectomy

European Journal of Radiology

Volumn 69, Issue 1, 2009, Pages 114-119

  Ikushima, Ichiro ^a   Higashi, Shushi ^a   Seguchi, Koji ^a   Ishii, Akihiko ^a   Ota, Yoshikazu ^a   Shima, Masayasu ^a   Kanemaru, Mikio ^a   Hidaka, Yoshiaki ^a  

^a Miyakonojo Medical Association Hospital   (Japan)

Author keywords

Hepatectomy; Recurrent hepatocellular carcinoma; Transarterial infusion; W O W emulsion

Indexed keywords

ANTI CANCER AGENTS; COMPLETE RESPONSES; EFFECTIVE RESPONSES; EPIRUBICIN; HEPATECTOMY; PARTIAL RESPONSES; RECURRENT HEPATOCELLULAR CARCINOMA; SURGICAL RESECTIONS; SURVIVAL CURVES; SURVIVAL TIMES; TRANSARTERIAL INFUSION; UP TIMES; W/O/W EMULSION; WATER EMULSIONS;

CHEMOTHERAPY; EMULSIONS; TUMORS;

EMULSIFICATION;

EPIRUBICIN;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; EMULSION; FEMALE; HUMAN; KAPLAN MEIER METHOD; LIVER ANGIOGRAPHY; LIVER CELL CARCINOMA; LIVER RESECTION; MALE; PRIORITY JOURNAL; SURVIVAL TIME; TREATMENT RESPONSE;

AGED; AGED, 80 AND OVER; ANTIBIOTICS, ANTINEOPLASTIC; CARCINOMA, HEPATOCELLULAR; DRUG CARRIERS; EMULSIONS; EPIRUBICIN; FEMALE; HEPATECTOMY; HUMANS; INFUSIONS, INTRA-ARTERIAL; LIVER NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; OILS; TREATMENT OUTCOME; WATER;

EID: 58149514048     PISSN: 0720048X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejrad.2007.09.001     Document Type: Article

References (24)

1. Higashi S., Shimizu M., Nakashima T., et al. Arterial-injection chemotherapy for hepatocellular carcinoma using monodispersed poppy-seed oil microdroplets containing fine aqueous vesicles of epirubicin. Initial medical application of a membrane-emulsification technique. Cancer 75 6 (1995) 1245-1254
2. Higashi S., Maeda Y., Kai M., et al. A case of hepatocellular carcinoma effectively treated with epirubicin aqueous vesicles in monodispersed iodized poppy-seed oil microdroplets. Hepatogastroenterology 43 12 (1996) 1427-1430
3. Higashi S., Tabata N., Kondo K.H., et al. Size of lipid microdroplets effects results of hepatic arterial chemotherapy with an anticancer agent in water-in-oil-in-water emulsion to hepatocellular carcinoma. J Pharmacol Exp Ther 289 2 (1999) 816-819
4. Higashi S., and Setoguchi T. Hepatic arterial injection chemotherapy for hepatocellular carcinoma with epirubicin aqueous solution as numerous vesicles in iodinated poppy-seed oil microdroplets: clinical application of water-in-oil-in-water emulsion prepared using a membrane emulsification technique. Adv Drug Deliv Rev 45 1 (2000) 57-64
5. Llovet J.M., Fuster J., and Bruix J. Intention-to-treat analysis of surgical treatment for early hepatocellular carcinoma: resection versus transplantation. Hepatology 30 6 (1999) 1434-1440
6. Arii S., Yamaoka Y., Futagawa S., et al. Results of surgical and nonsurgical treatment for small-sized hepatocellular carcinomas: a retrospective and nationwide survey in Japan. The Liver Cancer Study Group of Japan. Hepatology 32 6 (2000) 1224-1229
7. Takayama T., Makuuchi M., Hirohashi S., et al. Early hepatocellular carcinoma as an entity with a high rate of surgical cure. Hepatology 28 5 (1998) 1241-1246
8. Fong Y., Sun R.L., Jarnagin W., and Blumgart L.H. An analysis of 412 cases of hepatocellular carcinoma at a Western center. Ann Surg 229 6 (1999) 790-799 discussion 799-800
9. Grazi G.L., Ercolani G., Pierangeli F., et al. Improved results of liver resection for hepatocellular carcinoma on cirrhosis give the procedure added value. Ann Surg 234 1 (2001) 71-78
10. Okada S., Shimada K., Yamamoto J., et al. Predictive factors for postoperative recurrence of hepatocellular carcinoma. Gastroenterology 106 6 (1994) 1618-1624
11. Shirabe K., Kanematsu T., Matsumata T., Adachi E., Akazawa K., and Sugimachi K. Factors linked to early recurrence of small hepatocellular carcinoma after hepatectomy: univariate and multivariate analyses. Hepatology 14 5 (1991) 802-805
12. Adachi E., Maeda T., Matsumata T., et al. Risk factors for intrahepatic recurrence in human small hepatocellular carcinoma. Gastroenterology 108 3 (1995) 768-775
13. Poon R.T., Fan S.T., Lo C.M., Liu C.L., and Wong J. Intrahepatic recurrence after curative resection of hepatocellular carcinoma: long-term results of treatment and prognostic factors. Ann Surg 229 2 (1999) 216-222
14. Schwartz J.D., Schwartz M., Mandeli J., and Sung M. Neoadjuvant and adjuvant therapy for resectable hepatocellular carcinoma: review of the randomised clinical trials. Lancet Oncol 3 10 (2002) 593-603
15. Nakajima Y., Ko S., Kanamura T., et al. Repeat liver resection for hepatocellular carcinoma. J Am Coll Surg 192 3 (2001) 339-344
16. Matsuda M., Fujii H., Kono H., and Matsumoto Y. Surgical treatment of recurrent hepatocellular carcinoma based on the mode of recurrence: repeat hepatic resection or ablation are good choices for patients with recurrent multicentric cancer. J Hepatobiliary Pancreat Surg 8 4 (2001) 353-359
17. Nakoa N., Kamino K., Miura K., et al. Recurrent hepatocellular carcinoma after partial hepatectomy: value of treatment with transcatheter arterial chemoembolization. Am J Roentgenol 156 6 (1991) 1177-1179
18. Ramsey D.E., Kernagis L.Y., Soulen M.C., and Geschwind J.F. Chemoembolization of hepatocellular carcinoma. J Vasc Interv Radiol 13 9 Pt 2 (2002) S211-S221
19. Covey A.M., Maluccio M.A., Schubert J., et al. Particle embolization of recurrent hepatocellular carcinoma after hepatectomy. Cancer 106 10 (2006) 2181-2189
20. Geschwind J.F., Salem R., Carr B.I., et al. Yttrium-90 microspheres for the treatment of hepatocellular carcinoma. Gastroenterology 127 5 Suppl 1 (2004) S194-S205
21. Liu M.D., Uaje M.B., Al-Ghazi M.S., et al. Use of Yttrium-90 TheraSphere for the treatment of unresectable hepatocellular carcinoma. Am Surg 70 11 (2004) 947-953
22. Sato K., Lewandowski R.J., Bui J.T., et al. Treatment of unresectable primary and metastatic liver cancer with yttrium-90 microspheres (TheraSphere): assessment of hepatic arterial embolization. Cardiovasc Interv Radiol 29 4 (2006) 522-529
23. Boucher E., Garin E., Guylligomarc'h A., et al. Intra-arterial injection of iodine-131-labeled lipiodol for treatment of hepatocellular carcinoma. Radiother Oncol 82 1 (2007) 76-82
24. Raoul J.L., Guyader D., Bretagne J.F., et al. Randomized controlled trial for hepatocellular carcinoma with portal vein thrombosis: intra-arterial iodine-131-iodized oil versus medical support. J Nucl Med 35 11 (1994) 1782-1787